2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

被引:95
作者
Heidenreich, Paul A. [1 ]
Bozkurt, Biykem [2 ,3 ,4 ,5 ,6 ,7 ]
Aguilar, David [8 ]
Allen, Larry A. [9 ]
Byun, Joni J. [10 ]
Colvin, Monica M. [11 ,12 ]
Deswal, Anita [13 ,14 ]
Drazner, Mark H. [15 ]
Dunlay, Shannon M. [16 ]
Evers, Linda R. [17 ]
Fang, James C. [18 ]
Fedson, Savitri E. [19 ]
Fonarow, Gregg C. [20 ,21 ]
Hayek, Salim S. [22 ]
Hernandez, Adrian F. [23 ]
Khazanie, Prateeti [24 ]
Kittleson, Michelle M. [25 ]
Lee, Christopher S. [26 ]
Link, Mark S. [27 ,28 ,29 ]
Milano, Carmelo A. [30 ]
Nnacheta, Lorraine C. [31 ]
Sandhu, Alexander T. [32 ]
Stevenson, Lynne Warner [33 ,34 ]
Vardeny, Orly [35 ,36 ]
Vest, Amanda R. [37 ]
Yancy, Clyde W. [38 ,39 ,40 ,41 ,42 ,43 ]
机构
[1] Stanford Univ, Sch Med, Dept Med, Qual, Stanford, CA 94305 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Bakey VA Med Ctr Cardiol Dept Mary & Gordon Cain, Houston, TX USA
[4] DeBakey VA Med Ctr, Med Med Care Line Execut, Houston, TX USA
[5] Winters Ctr Heart Failure Res, Houston, TX USA
[6] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA
[7] Baylor Coll Med, Med, Houston, TX 77030 USA
[8] Univ Kentucky, Med, Dept Med, Div Cardiovasc Med, Lexington, KY 40506 USA
[9] Univ Colorado, Sch Med, Med, Dept Med,Div Cardiol, Anschutz Med Campus, Boulder, CO 80309 USA
[10] Penultimate PR, Boulder, CO USA
[11] Univ Michigan, Med, Dept Med, Cardiovasc Div, Ann Arbor, MI 48109 USA
[12] Univ Michigan, Heart Transplant Program, Adv Heart Failure Transplant & MCS Natera, Ann Arbor, MI 48109 USA
[13] UT MD Anderson Canc Ctr, Med, Houston, TX USA
[14] UT MD Anderson Canc Ctr, Cardiol, Houston, TX USA
[15] UT Southwestern Med Ctr, Cardiol, Dept Internal Med, Dallas, TX USA
[16] Mayo Clin, Hlth Serv Res & Med, Dept Cardiovasc Med, Rochester, MN USA
[17] Stevens & Lee Shareholder, Stevens & Lees Energy, Commun & Publ Util Grp, Trenton, NJ USA
[18] Univ Utah, Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA
[19] Michael E DeBakey Med Ctr, Adv Heart Failure & Transplantat, Cardiol Sect, Houston, TX USA
[20] Univ Calif Los Angeles, Geffen Sch Med, Cardiovasc Med, Los Angeles, CA 90024 USA
[21] Univ Calif Los Angeles, Div Cardiol, Dept Med, Los Angeles, CA 90024 USA
[22] Univ Michigan, Dept Med, Div Cardiol, Ann Arbor, MI 48109 USA
[23] Duke Univ, Sch Med, Clin Res, Durham, NC 27706 USA
[24] Univ Colorado, Med, Dept Med, Div Cardiol, Boulder, CO 80309 USA
[25] Smidt Heart Inst Cedars Sinai, Med, Cardiol, Los Angeles, CA USA
[26] Boston Coll, William F Connell Sch Nursing, Res, Chestnut Hill, MA 02167 USA
[27] UT Southwestern Med Ctr, Med, Dallas, TX USA
[28] UT Southwestern Med Ctr, Cardiac Electrophysiol, Dallas, TX USA
[29] UT Southwestern Med Ctr, Heart Dis, Dept Internal Med, Div Cardiol, Dallas, TX USA
[30] Duke Univ, Med Ctr, Surg, Dept Surg, Durham, NC 27706 USA
[31] Amer Heart Assoc, Amer Coll Cardiol, Dallas, TX USA
[32] Stanford Univ, Med, Div Cardiol, Dept Med, Stanford, CA 94305 USA
[33] Vanderbilt Univ, Med Ctr, Vanderbilt Heart & Vasc Inst, Cardiomyopathy, Nashville, TN USA
[34] Vanderbilt Univ, Med Ctr, Vanderbilt Heart & Vasc Inst, Cardiovasc Med, Nashville, TN USA
[35] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA
[36] Univ Minnesota, Med, Dept Med, Minneapolis, MN 55455 USA
[37] Tufts Med Ctr, Cardiovasc Ctr, Med, Boston, MA 02111 USA
[38] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
[39] Northwestern Mem Hosp, Med Cardiol, Chicago, IL 60611 USA
[40] Northwestern Mem Hosp, Med Social Sci, Chicago, IL 60611 USA
[41] Northwestern Mem Hosp, Cardiol, Chicago, IL 60611 USA
[42] Northwestern Mem Hosp, Divers & Inclus, Chicago, IL 60611 USA
[43] Northwestern Mem Hosp, Cardiovasc Inst Internal Med Cardiol & Med Social, Chicago, IL 60611 USA
关键词
AHA Scientific Statements; heart failure; heart failure with reduced ejection fraction; heart failure with preserved ejection fraction; heart failure with mildly reduced ejection fraction; systolic heart failure; heart failure rehabilitation; cardiac failure; chronic heart failure; acute decompensated heart failure; cardiogenic shock; beta blockers; mineralocorticoid receptor antagonists; ACE inhibitors; angiotensin and neprilysin receptor antagonist; sacubitril valsartan; angiotensin receptor antagonist; sodium glucose co-transporter 2; SGLT2; inhibitors; cardiac amyloidosis; atrial fibrillation; congestive heart failure; guideline-directed medical therapy; diabetes; cardiomyopathy; valvular heart disease; mitral regurgitation; cardiomyopathy in pregnancy; reduced ejection fraction; right heart pressure; palliative care; cardio-oncology; social determinants of health; CARDIAC-RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR DYSFUNCTION; QUALITY-OF-LIFE; PRESERVED EJECTION FRACTION; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; MECHANICAL CIRCULATORY SUPPORT; BRAIN NATRIURETIC PEPTIDE; CORONARY-ARTERY-DISEASE; FUNCTIONAL MITRAL REGURGITATION;
D O I
10.1161/CIR.0000000000001063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. Methods: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Structure: Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
引用
收藏
页码:E895 / E1032
页数:138
相关论文
共 1528 条
  • [1] Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
    Aaronson, KD
    Schwartz, JS
    Chen, TM
    Wong, KL
    Goin, JE
    Mancini, DM
    [J]. CIRCULATION, 1997, 95 (12) : 2660 - 2667
  • [2] Risk of cardiovascular toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis
    Abdel-Rahman, Omar
    Fouad, Mona
    [J]. FUTURE ONCOLOGY, 2014, 10 (12) : 1981 - 1992
  • [3] Abdelrahman M, 2018, J AM COLL CARDIOL, V71, P2581, DOI [10.1016/j.jacc.2018.02.048, 10.1016/S0735-1097(18)33122-X]
  • [4] Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis
    Abraham, Jacob
    Bharmi, Rupinder
    Jonsson, Orvar
    Oliveira, Guilherme H.
    Artis, Andre
    Valika, Ali
    Capodilupo, Robert
    Adamson, Philip B.
    Roberts, Gregory
    Dalal, Nirav
    Desai, Akshay S.
    Benza, Raymond L.
    [J]. JAMA CARDIOLOGY, 2019, 4 (06) : 556 - 563
  • [5] A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
    Abraham, William T.
    Kuck, Karl-Heinz
    Goldsmith, Rochelle L.
    Lindenfeld, JoAnn
    Reddy, Vivek Y.
    Carson, Peter E.
    Mann, Douglas L.
    Saville, Benjamin
    Parise, Helen
    Chan, Rodrigo
    Wiegn, Phi
    Hastings, Jeffrey L.
    Kaplan, Andrew J.
    Edelmann, Frank
    Luthje, Lars
    Kahwash, Rami
    Tomassoni, Gery F.
    Gutterman, David D.
    Stagg, Angela
    Burkhoff, Daniel
    Hasenfuss, Gerd
    [J]. JACC-HEART FAILURE, 2018, 6 (10) : 874 - 883
  • [6] Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial
    Abraham, William T.
    Adamson, Philip B.
    Bourge, Robert C.
    Aaron, Mark F.
    Costanzo, Maria Rosa
    Stevenson, Lynne W.
    Strickland, Warren
    Neelagaru, Suresh
    Raval, Nirav
    Krueger, Steven
    Weiner, Stanislav
    Shavelle, David
    Jeffries, Bradley
    Yadav, Jay S.
    [J]. LANCET, 2011, 377 (9766) : 658 - 666
  • [7] In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications - An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)
    Abraham, WT
    Adams, KF
    Fonarow, GC
    Costanzo, MR
    Berkowitz, RL
    LeJemtel, TH
    Cheng, ML
    Wynne, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) : 57 - 64
  • [8] Cardiac resynchronization in chronic heart failure
    Abraham, WT
    Fisher, WG
    Smith, AL
    Delurgio, DB
    Leon, AR
    Loh, E
    Kocovic, DZ
    Packer, M
    Clavell, AL
    Hayes, DL
    Ellestad, M
    Messenger, J
    Trupp, RJ
    Underwood, J
    Pickering, F
    Truex, C
    McAtee, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) : 1845 - 1853
  • [9] Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy
    Abu-Khalaf, Maysa M.
    Safonov, Anton
    Stratton, Jamie
    Wang, Shiyi
    Hatzis, Christos
    Park, Esther
    Pusztai, Lajos
    Gross, Cary P.
    Russell, Raymond
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 261 - 270
  • [10] Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy
    Acharya, Deepak
    Sanam, Kumar
    Revilla-Martinez, Marina
    Hashim, Taimoor
    Morgan, Charity J.
    Pamboukian, Salpy V.
    Loyaga-Rendon, Renzo Y.
    Tallaj, Jose A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06) : 952 - 956